Disease burden and unmet need for acute allergic reactions - A patient perspective.

ABSTRACT:

Background

Acute allergic reactions (AARs) occur shortly after exposure to an allergen, and the severity is on a continuum. Systemic corticosteroids (CS) are mainstay treatment of moderate to severe AARs, whereas those at risk of the most severe AARs (ie, anaphylaxis) are also recommended prescription of epinephrine autoinjectors. There is limited research on the impact of AARs not fulfilling the criteria for anaphylaxis. We have characterized a sample with a history of moderate to severe AARs and evaluated their self-reported disease burden (ie, daily life impact, anxiety, and treatment impediments).

Methods

Survey study of adults with experience of AARs treated with CS. Participants recruited from a web-based panel and using social media were asked to complete a questionna

SUBMITTER: Andersson E 

PROVIDER: S-EPMC10990897 | biostudies-literature | 2024 Apr

REPOSITORIES: biostudies-literature